Human atrial β1L-adrenoceptor but not β3-adrenoceptor activation increases force and Ca2+ current at physiological temperature

Tissue functions mediated by β3-adrenoceptors—findings and challenges

(2010) Martin C. Michel et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

CLINICAL PROOF OF CONCEPT STUDY (BLOSSOM) SHOWS NOVEL β3 ADRENOCEPTOR AGONIST YM178 IS EFFECTIVE AND WELL TOLERATED IN THE TREATMENT OF SYMPTOMS OF OVERACTIVE BLADDER

(2008) C.R. Chapple et al.   EUROPEAN UROLOGY SUPPLEMENTS

Effects of the β3-Adrenergic Agonist BRL 37344 on Endothelial Nitric Oxide Synthase Phosphorylation and Force of Contraction in Human Failing Myocardium

(2008) Andreas Napp et al.   JOURNAL OF CARDIAC FAILURE

Catecholamines Relax Detrusor through  2-Adrenoceptors in Mouse and  3-Adrenoceptors in Man

(2008) M. Wuest et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from β3-adrenoceptor agonists

(2008) Jonathan R. S. Arch   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

The low-affinity site of the β1-adrenoceptor and its relevance to cardiovascular pharmacology

(2008) Alberto J. Kaumann et al.   PHARMACOLOGY & THERAPEUTICS